NASDAQ
Caribou Biosciences, Inc. (CRBU) has a price/sales ratio of 13.31x as of Friday, May 22, 2026. This represents a 64.27% decrease compared to its 12-month average of 37.24x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.